350 related articles for article (PubMed ID: 15683457)
1. Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.
Ostrowski SR; Plomgaard P; Fischer CP; Steensberg AS; Møller K; Høyer-Hansen G; Pedersen BK; Ullum H
Scand J Immunol; 2005 Feb; 61(2):197-206. PubMed ID: 15683457
[TBL] [Abstract][Full Text] [Related]
2. Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.
Ostrowski SR; Piironen T; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
Scand J Immunol; 2005 Apr; 61(4):347-56. PubMed ID: 15853918
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia.
Shannon E; Noveck R; Sandoval F; Kamath B; Kearney M
Transl Res; 2007 Nov; 150(5):275-80. PubMed ID: 17964516
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
Mustjoki S; Sidenius N; Sier CF; Blasi F; Elonen E; Alitalo R; Vaheri A
Cancer Res; 2000 Dec; 60(24):7126-32. PubMed ID: 11156421
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.
Conti P; Feliciani C; Barbacane RC; Panara MR; Reale M; Placido FC; Sauder DN; Dempsey RA; Amerio P
Immunology; 1992 Oct; 77(2):245-50. PubMed ID: 1427978
[TBL] [Abstract][Full Text] [Related]
6. Secretion of interleukin-6 by peripheral blood mononuclear cells from patients with pulmonary tuberculosis and their contacts.
Saunders R; Robson S; Soule S; Kirsch RE
J Clin Lab Immunol; 1993; 40(1):19-28. PubMed ID: 7932624
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.
Haider DG; Leuchten N; Schaller G; Gouya G; Kolodjaschna J; Schmetterer L; Kapiotis S; Wolzt M
Clin Exp Immunol; 2006 Dec; 146(3):533-9. PubMed ID: 17100775
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.
Holst-Hansen C; Hamers MJ; Johannessen BE; Brünner N; Stephens RW
Br J Cancer; 1999 Sep; 81(2):203-11. PubMed ID: 10496343
[TBL] [Abstract][Full Text] [Related]
10. Suppression of IL-6 level in human peripheral blood mononuclear cells stimulated with PHA/LPS after occupational exposure to chromium.
Katiyar S; Awasthi SK; Sahu RK
Sci Total Environ; 2008 Feb; 390(2-3):355-61. PubMed ID: 18031794
[TBL] [Abstract][Full Text] [Related]
11. Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures.
Chao CC; Hu S; Molitor TW; Zhou Y; Murtaugh MP; Tsang M; Peterson PK
J Pharmacol Exp Ther; 1992 Jul; 262(1):19-24. PubMed ID: 1625199
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers.
Wirtz PH; von Känel R; Kunz-Ebrecht S; Ehlert U; Fischer JE
Brain Behav Immun; 2004 Nov; 18(6):536-43. PubMed ID: 15331124
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients.
Begum FD; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Bock JE; Glud E; Høyer-Hansen G; Ring-Larsen H; Høgdall EV
Anticancer Res; 2004; 24(3b):1981-5. PubMed ID: 15274388
[TBL] [Abstract][Full Text] [Related]
14. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.
Schäfer C; Schips I; Landig J; Bode JC; Bode C
Z Gastroenterol; 1995 Sep; 33(9):503-8. PubMed ID: 8525652
[TBL] [Abstract][Full Text] [Related]
15. The effect of TNF-alpha, PMA, and LPS on plasma and cell-associated IL-8 in human leukocytes.
Lund T; Østerud B
Thromb Res; 2004; 113(1):75-83. PubMed ID: 15081568
[TBL] [Abstract][Full Text] [Related]
16. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G
Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103
[TBL] [Abstract][Full Text] [Related]
17. Soluble IL-6 receptor release by PMNs and PBMC in patients with oral cavity cancer.
Jabłońska E; Piotrowski L; Grabowska Z
Rocz Akad Med Bialymst; 1997; 42(1):99-106. PubMed ID: 9581469
[TBL] [Abstract][Full Text] [Related]
18. Low-dose endotoxemia and human neuropsychological functions.
Krabbe KS; Reichenberg A; Yirmiya R; Smed A; Pedersen BK; Bruunsgaard H
Brain Behav Immun; 2005 Sep; 19(5):453-60. PubMed ID: 15963684
[TBL] [Abstract][Full Text] [Related]
19. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans.
Granowitz EV; Porat R; Mier JW; Orencole SF; Kaplanski G; Lynch EA; Ye K; Vannier E; Wolff SM; Dinarello CA
J Immunol; 1993 Aug; 151(3):1637-45. PubMed ID: 7687636
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.
DeLa Cadena RA; Majluf-Cruz A; Stadnicki A; Tropea M; Reda D; Agosti JM; Colman RW; Suffredini AF
Thromb Haemost; 1998 Jul; 80(1):114-8. PubMed ID: 9684796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
